Balaji Borlepwar has taken over as Executive Vice President – India GX & Wellness Divisions at Micro Labs Ltd., & completed successful 1 year at Micro Lab Ltd. Bringing with him a wealth of experience in leading pharmaceutical brands across India. In his new role, Balaji will focus on strengthening Micro Labs’ position in the generic and wellness segments, while driving innovation and sustainable growth.
With nearly three decades of experience in the healthcare industry, Balaji has led high-impact teams across sales, marketing, and strategy functions. At Cipla Ltd – Generic Division he played a pivotal role in building strong market presence and delivering consistent business outcomes through his leadership across senior roles, including as Group Head and Vice President.
His early professional journey includes leadership roles at Lupin and a long, impactful tenure at Cipla, where he helped to make NO 1 company in Gx space & expand the reach of generic medicines across multiple regions. Known for his strategic mindset and execution excellence, Balaji is deeply committed to improving patient access through trusted and affordable healthcare solutions.
An MBA in Marketing from Symbiosis Institute of Business Management, Balaji combines academic strength with grassroots field experience. At Micro Labs, he is poised to lead the India Gx & Wellness Divisions into their next phase of growth, with a focus on operational efficiency, market expansion, and patient-centric innovation.